Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples